Loading stock data…
DaVita Inc. (DVA)
$235.44+1.17 (+0.50%)
Market ClosedLast close Jul 24
DaVita Inc.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
DaVita Inc. in the Healthcare sector is trading at $235.44 with a market capitalization of $12.5B. Wall Street consensus targets $208.57 (7 analysts), implying a -11.4% move over the next 12 months. The stock is currently near its 52-week high of $239.64, remaining 53.0% above its 200-day moving average. On fundamentals, Piotroski 6/9 shows mixed financial quality, Altman Z in the distress zone. The Whystock Score of 65/100 suggests a balanced risk-reward profile.
Ecosystem Influences
Sell-side targets imply -11.4% downside over 12 months
Long-term trend bullish (price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Quarterly Financials
| Metric (USD) | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Total Revenue | $3.42B↓ | $3.62B↑ | $3.42B↑ | $3.38B↑ | $3.22B |
| Gross Profit | $1.07B↓ | $1.21B↑ | $1.09B↓ | $1.12B↑ | $983.87M |
| Operating Income | $473.55M↓ | $551.21M↑ | $495.61M↓ | $530.48M↑ | $433.33M |
| Net Income | $197.53M↓ | $234.22M↑ | $150.33M↓ | $199.34M↑ | $162.92M |
Peer Comparison
JNJUNHPFE
Fundamentals
DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpa...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$12.52B
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
18.77
Beta
Defensive asset. Lower volatility than the S&P 500.
0.84
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
-103.43%
Volume
Today's trading volume
438,864
Recent News
Moon Capital Management Exited DaVita (DVA) with 174% total Return
Moon Capital Management, LLC, an investment management company, released its second quarter 2025 investor letter. A copy of the letter can be downloaded here. The S&P 500 index rebounded in the second quarter, achieving a 9.6% return for the first half of the year, while Moon Capital Management’s equity portfolio gained 4%. AI-related stocks led […]
3 S&P 500 Stocks We Think Twice About
While the S&P 500 (^GSPC) includes industry leaders, not every stock in the index is a winner. Some companies are past their prime, weighed down by poor execution, weak financials, or structural headwinds.
DaVita HealthCare (DVA) Advances While Market Declines: Some Information for Investors
DaVita HealthCare (DVA) reached $236.97 at the closing of the latest trading day, reflecting a +1.26% change compared to its last close.
3 Profitable Stocks We Think Twice About
Even if a company is profitable, it doesn’t always mean it’s a great investment. Some struggle to maintain growth, face looming threats, or fail to reinvest wisely, limiting their future potential.
DaVita HealthCare (DVA) Rises As Market Takes a Dip: Key Facts
In the closing of the recent trading day, DaVita HealthCare (DVA) stood at $234.01, denoting a +1.04% move from the preceding trading day.